ArticleJAMA network open2026

Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes.

Christopher D Hamad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.